BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shimizu T, Motosugi U, Komatsu N, Ichikawa S, Inoue T, Onishi H, Enomoto N. MRI-based risk factors of hepatocellular carcinoma in patients with chronic liver disease: A prospective observational study. J Magn Reson Imaging 2020;51:389-96. [PMID: 31120640 DOI: 10.1002/jmri.26797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Philips CA, Rajesh S, Nair DC, Ahamed R, Abduljaleel JK, Augustine P. Hepatocellular Carcinoma in 2021: An Exhaustive Update. Cureus 2021;13:e19274. [PMID: 34754704 DOI: 10.7759/cureus.19274] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
2 Motosugi U. Improving Postsurgical Outcome in Patients with HCC by Using a Hepatobiliary Contrast Agent. Radiology 2019;293:605-6. [PMID: 31596183 DOI: 10.1148/radiol.2019191990] [Reference Citation Analysis]